Syn-One Test Commercialization
Parkinson's Disease, Dementia with Lewy Bodies, Multiple System Atrophy
CommercialActive
Key Facts
Indication
Parkinson's Disease, Dementia with Lewy Bodies, Multiple System Atrophy
Phase
Commercial
Status
Active
Company
About CND Life Sciences
CND Life Sciences is a pioneering diagnostics company focused on transforming the clinical approach to neurodegenerative diseases through its proprietary skin biopsy technology. Its flagship Syn-One Test, which has performed over 50,000 patient tests, provides objective pathological confirmation of synucleinopathies with high reported accuracy (>95% sensitivity and specificity). The company is commercial, revenue-generating, and expanding its geographic and strategic footprint, including supporting biopharma clinical trials, while navigating a competitive and reimbursement-sensitive market.
View full company profile